Recent Study: Morocco Pharmaceuticals & Healthcare Report Q1 2015

From: Fast Market Research, Inc.
Published: Mon Jan 19 2015

Our outlook for Morocco's pharmaceutical market remains relatively optimistic over the short-to-long term. Increased access to healthcare in Morocco following the implementation of the final phase of its universal health insurance scheme will drive an increase in pharmaceutical spending. The country's reliance on pharmaceutical imports will provide opportunities for multinational drugmakers, though the inefficient regulatory environment is a risk to operating in Morocco .

Headline Expenditure Projections

* Pharmaceuticals: MAD10.37bn (USD1.23bn) in 2013 to MAD10.53bn (USD1.28bn) in 2014; +1.6% in local currency terms and +4.0% in US dollar terms. Forecast increased from last quarter due to upward revision of historical data.
* Healthcare: MAD57.78bn (USD6.87bn) in 2013 to MAD62.58bn (USD7.62bn) in 2014; +8.3% in local currency terms and +10.8% in US dollar terms.

Full Report Details at

Risk/Reward Index

In our latest proprietary Pharmaceutical Risk/Reward Index (RRI), Morocco continues to be viewed as a moderately attractive pharmaceutical market in the Middle East and Africa (MEA) region, from a longer-term perspective. Morocco ranks 15 th in the region, out of the 31 countries assessed, with a score of 41.1 out of 100. The market's constraints include low per capita consumption and an underdeveloped reimbursement system, although such factors are to a degree offset by a relatively predictable operating environment.

Key Trends And Developments

October 2014

The first clinic exclusively for treating all kinds of infertility related cases was opened in Marrakech city in Morocco. The clinic was built at a cost of MAD20mn (USD2.3mn) and spans more than 900sqm, according to specialist in gynaecology and obstetrics Hassan Bodrar. The integrated clinic includes a specialist laboratory with the latest equipment and techniques, modern rooms for operations and specialised doctors. Lack of awareness about fertility problems in Morocco (unlike in neighbouring counties, such as...

The Morocco Pharmaceuticals & Healthcare Report features Business Monitor International (BMI)'s forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Morocco Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Moroccan pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's independent pharmaceutical and healthcare industry forecasts for Morocco to test other views - a key input for successful budgeting and strategic business planning in the Moroccan pharmaceutical and healthcare market.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Malaysia Pharmaceuticals & Healthcare Report Q1 2015
- Peru Pharmaceuticals & Healthcare Report Q1 2015
- Lebanon Pharmaceuticals & Healthcare Report Q1 2015
- Oman Pharmaceuticals & Healthcare Report Q1 2015
- Turkey Pharmaceuticals & Healthcare Report Q1 2015
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »